Abstract: The present invention relates to a process for producing a low endotoxin alkali chitosan, chitin, chitosan derivative or chitin derivative, and also to a process for producing low endotoxin neutral chitosan, chitosan salt and chitosan derivatives, and to the products of such processes. The process comprises contacting chitosan, chitin, chitosan derivative or chitin derivative with an alkali solution to form a mixture; leaving the mixture for a period of less than 1 hour and optionally drying the mixture. The low endotoxin alkali chitosan may be used in the manufacture of other useful chitosan based products.

Abstract: The disclosed exemplary embodiments include computer-implemented systems, apparatuses, devices, and processes that, among other things, dynamically provision exchanges of data based on detected relationships within processed image data. For example, a network-connected apparatus may receive, from a device, image data that identifies a plurality of individuals associated with an exchange of data. Based on an analysis of the image data, the apparatus may determine a value of a first characteristic associated with each of the individuals and generate relationship data characterizing a relationship between the individuals. The apparatus may also determine candidate values of parameters that characterize the data exchange based on portions of the first characteristic values and the relationship data, transmit the candidate parameter values to the device. An application program executed by the device may cause the device to present at least a portion of the candidate parameter values within a digital interface.

Abstract: The disclosed exemplary embodiments include computer-implemented systems, apparatuses, devices, and processes that, among other things, dynamically provision exchanges of data based on detected relationships within processed image data. For example, a network-connected apparatus may receive, from a device, image data that identifies a plurality of individuals associated with an exchange of data. Based on an analysis of the image data, the apparatus may determine a value of a first characteristic associated with each of the individuals and generate relationship data characterizing a relationship between the individuals. The apparatus may also determine candidate values of parameters that characterize the data exchange based on portions of the first characteristic values and the relationship data, transmit the candidate parameter values to the device. An application program executed by the device may cause the device to present at least a portion of the candidate parameter values within a digital interface.

Abstract: A sensor for monitoring utility poles includes a sensing module to detect a physical quantity from a utility pole or a conductor supported by a utility pole to which the sensor is attached in use. A power supply supplies power to the device and a memory for storing sensor data. A communications module is used for transmitting and receiving sensor data to and from one or more sensors which are attached to other utility poles located adjacent to or nearby the utility pole. A processor uses the detected sensor data together with received sensor data to calculate if the utility pole to which the sensor is attached has changed its physical condition, and wherein if the processor calculates that the utility pole to which the sensor is attached has changed its physical condition, a message is transmitted via the communications module to a remote server.

Abstract: The invention is a pharmaceutical composition of human insulin or insulin analog that includes citrate, treprostinil and stabilizing agents, that has faster pharmacokinetic and/or pharmacodynamic action than commercial formulations of existing insulin analog products and that is stable for commercial use.

Abstract: A method for processing results of database queries is disclosed.

Abstract: The invention is a pharmaceutical composition of human insulin or insulin analog that includes citrate, treprostinil and stabilizing agents, that has faster pharmacokinetic and/or pharmacodynamic action than commercial formulations of existing insulin analog products and that is stable for commercial use.

Abstract: The disclosed exemplary embodiments include computer-implemented systems, apparatuses, devices, and processes that, among other things, dynamically provision exchanges of data based on detected relationships within processed image data. For example, a network-connected apparatus may receive, from a device, image data that identifies a plurality of individuals associated with an exchange of data. Based on an analysis of the image data, the apparatus may determine a value of a first characteristic associated with each of the individuals and generate relationship data characterizing a relationship between the individuals. The apparatus may also determine candidate values of parameters that characterize the data exchange based on portions of the first characteristic values and the relationship data, transmit the candidate parameter values to the device. An application program executed by the device may cause the device to present at least a portion of the candidate parameter values within a digital interface.

Abstract: Embodiments conveyed herein seek to disclose an apparatus, system, and method to protect an epithelial layer from surface contaminants. The apparatus can include a portable enclosure that includes an internal space(s). At least one deployable covering can be affixed to a surface of one of the internal spaces. The apparatus can have a deployed state and a closed state. The deployable covering may extend distal to the portable enclosure in the “deployed” state and may be positioned within the internal space in the closed state. The system can include a bench having at least one functional surface and the apparatus can be positioned proximate to functional surfaces. Deployable coverings may be positioned adjacent to and coplanar with functional surfaces. The method can include converting the apparatus from closed to deployed and positioning the deployable covering(s) adjacent to and coplanar with at least one functional surface.

Abstract: The invention is a composition of human insulin or insulin analog that includes treprostinil and that has faster pharmacokinetic action than commercial formulations of existing insulin analog products.

Abstract: The invention is a pharmaceutical composition of human insulin or insulin analog that includes citrate, treprostinil and stabilizing agents, that has faster pharmacokinetic and/or pharmacodynamic action than commercial formulations of existing insulin analog products and that is stable for commercial use.

Abstract: The invention is a pharmaceutical composition of human insulin or insulin analog that includes citrate, treprostinil and stabilizing agents, that has faster pharmacokinetic and/or pharmacodynamic action than commercial formulations of existing insulin analog products and that is stable for commercial use.

Abstract: The invention is a pharmaceutical composition of human insulin or insulin analog that includes citrate, treprostinil and stabilizing agents, that has faster pharmacokinetic and/or pharmacodynamic action than commercial formulations of existing insulin analog products and that is stable for commercial use.

Abstract: The invention is a composition of human insulin or insulin analog that includes treprostinil and that has faster pharmacokinetic action than commercial formulations of existing insulin analog products.

Abstract: Monitoring a user's exposure to ultraviolet radiation, including determining the amount of radiation to which the user is exposed from different directions, respectively.

Abstract: The invention is a composition of human insulin or insulin analog that includes treprostinil and that has faster pharmacokinetic action than commercial formulations of existing insulin analog products.

Abstract: Monitoring a user's exposure to ultraviolet radiation, including determining the amount of radiation to which the user is exposed from different directions, respectively.

Abstract: The invention is a composition of human insulin or insulin analog that includes treprostinil and that has faster pharmacokinetic action than commercial formulations of existing insulin analog products.